Trial
NCT03364738
Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Shire
Collaborators
—
Condition
Hypoparathyroidism
Intervention
rhPTH(1-84)
Why stopped
The study was terminated due to Takeda commercial Natpara recall.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-07